A Common Drug Offers New Hope to People With Severe Hair Loss

Two major trials show a JAK inhibitor drug helped over half of severe alopecia patients regrow most of their hair.

THOUSANDS of adults and teenagers with severe hair loss could benefit from a drug already prescribed on the NHS. Upadacitinib, sold under the brand name Rinvoq, is currently offered by the health service to treat Crohn’s Disease or Ulcerative Colitis. But, according to US scientists, the once-a-day pill may also trigge

A new recommendation from Canada’s Drug Agency could make an Alzheimer’s treatment more accessible to Canadians in the early stages of the disease.